process engineer -np ê 6 -e`}s`uepea`...

Post on 26-Jul-2020

1 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

Perfluorinated Compounds in Drinking Water:Risks, Considerations, & Solutions

Dustin Mobley, P.E.Process Engineer

Water Technology Group

April 17, 2019

Agenda

• Background

• Properties & Application

• Health Effects

• Contamination Routes

• Occurrence

• Regulatory Status

• PFAS Treatment

• Risks, Considerations, & Solutions

2

PFAS Background

What is PFAS?

• Per- and Poly-Fluoro Alkyl Substances

• Synthetic Chemicals

• Persistent, bioaccumulative and some exhibit adverse health

effects

• Pervasive

• Ubiquitous

• Largely Unregulated

PFAS are commonly found in human and animal populations worldwide and are not metabolized

4

Chemistry of PFAS

• C-F bonds

• Strong, Stable, Persistent

• Fluorinated carbon chain

• Water- and Oil Resistant

• Length contributes to persistence, bioaccumulation

• Functional Groups Yield Useful Properties

• Coatings

• Surfactants

• Dispersants

PFAS properties benefit a wide range of applications but promote migration through the environment

5

PFAS Structures

6

Over 3,000 PFAS in use today

PFAS History

As legacy PFAS are phased out, new short-chain PFAS are introduced.

2016 - EPA sets health advisory

for PFOA and PFOS of 70 ng/L.

2018 - EPA holds national

leadershipsummit for

PFAS.

7

Polyfluorinated Compounds: Past, Present & FutureLindstrom et al., Env. Sci. & Tech.

Applications

Numerous pathways for contamination and human exposure

Firefighting Foams Non-stick Cookware Oil Recovery Food Packaging

Cosmetics Paints & Inks Coatings & Textiles Medical Devices

8

Health Effects

• Readily adsorbed through ingestion

• Inhalation & dermal exposures not studied

• Not metabolized (long half-lives)

• Crosses placenta and into breast milk

• Known adverse effects:• Pregnancy complications

• Liver damage

• Increased risks of asthma, thyroid disease, infertility

• Increases in cholesterol (total, LDL)

• Suggestive evidence of additional adverse effects

Need analytical methods to perform health studies

9

Common Contamination Routes

• Military Bases & Fire-Fighting Schools

• Use of Aqueous Fire-Fighting Foams (AFFF)

• Waste Disposal

• Runoff

• Landfill Leachate

• Manufacturing

• Air Emissions

• Wastewater Discharges

Preventing contamination at the source is key

10

11Likely that contamination is grossly underestimated.

Regulatory Efforts

Regulatory Status (Federal Level)

• EPA Health advisories (2016):

• PFOA < 70 ng/L

• PFOS < 70 ng/L

• Measured individually or combined

• ATSDR Draft Toxicological Profile for PFAS

• PFOA, PFNA, PFHxS, PFOS

• Values up to 10x lower than current HAs

• EPA Draft Toxicological Profile for GenX & PFBS

Lack of health studies on PFAS makes rule-making difficult and slow.

13

EPA PFAS Action Plan

Common theme is information gathering.

Key Actions:

• Begin MCL setting process for PFOA & PFOS

• Designate PFOA & PFOS as CERCLA hazardous substances

• Finalize outstanding toxicity assessments + more

• Repeat nationwide sampling (UCMR5)

14

Issued February 2019

Regulatory Status (State Level)

Some states dealing with PFAS contamination have developed guidance values more stringent than EPA health advisories.

Information from www.itrcweb.org

15

PFAS guidance

PFAS MCL

Federal• PFOA 70 ppt• PFOS 70 ppt

Michigan• PFOA 9 ppt• PFOS 8 ppt• PFNA 9 ppt• PFHxS 84 ppt• PFBS 1,000 ppt

New Jersey• PFOA 14 ppt• PFOS 13 ppt• PFNA 13 ppt (MCL)

PFAS Solutions

Problem Definition & Treatment Goals

Know Your Contaminants

• Measurable, not measurable

• Concentration

• Long-chain, short-chain

• Sulfonates, carboxylic acids

GenX, 6.3%

PFOA, 4.0%

PFOS, 1.6%

PFHpA, 8.4%

PFHxA, 14.0%

PFNA, 0.7%

PFBA, 1.1%

PFBS, 1.1%

PFPeA, 14.3%

PFPeS, 0.2%PFHxS, 1.4%

PFDA, 0.4%

Estimated Compounds

*, 46.5%

Selecting the treatment goal is perhaps as challenging as determining the most cost effective means to remove the contaminants.

17

External Factors

Solutions must consider technical, political, public relations, and regulatory components.

• PFAS Regulations/Guidance

•Unknowns

•Available Health Studies

• Customer expectations

•Rates/Cost

• Level of removal (non-detect)

•Other desired outcomes

18

Universe of PFAS Solutions

No one-size-fits-all solution for treatment of PFAS.

• Treatment (individual vs. regionalized)

•Granular Activated Carbon

• Ion Exchange

•Reverse Osmosis

• Purchase treated water

•New water supplies (well or surface)

• Blending

19

Best Available Technology – GAC/IX

• Granular activated carbon – most widely applied

• Scheduled media replacement

• Staggered replacement yields lower cost

• Piloting recommended to evaluate:

• Media selection

• Expected PFAS removal

• Media replacement can impact operations

IX and GAC replacement driven by influent concentration and treatment goal. 20

Membrane Processes

• Applicable to reverse osmosis

• Near complete removal of all PFASs (95 percent removal)

• Can be combined with GAC or IX for greater removal

• Requires ~15% more raw water

• High levels of PFAS in concentrate stream

• Inland desalination very costly

• Need for pre- and post-treatment

RO becomes more favorable with high concentrations of PFAS

21

Available Treatment Technologies

Technology CAPEX OPEX Pros Cons

GAC $$$ - $$

Varies withreplacement

• Removes wide range of organics

• Removes from environment• Re-useable media

• More frequency replacement• Low adsorption capacity• Early breakthrough of short

chain PFASs

IX $$$ - $$

Varies withreplacement

• Targeted removal of PFASs• Higher adsorption capacity• Removes from environment• Less frequent replacement

• Single use media• Removal of short chain PFASs• Removes few other

contaminants

RO $$$$$ - $$$

Varies with effluent goal

• High level of PFAS removal• Removes other contaminants• Indiscriminately removes all

contaminants

• Concentrated waste stream • Requires post treatment

stabilization

22

• Breakthrough order based on

• Straight carbon length

• Sulfate or acid functional group

• Treatment validation/optimization

• Doubling the EBCT resulted in 70% improvement in GAC replacement

• Adjusting replacement provides flexibility in uncertain regulatory environment

Piloting provides certainty in the selected treatment method.

The Importance of Piloting

23

Keys to dealing with PFAS:Knowledge + Communications

• Understand what compounds are present

• Develop reliable capital and cost models

• Evaluate various solutions

• Cost impact to consumer

• Flexibility if regulations change

• Proactive communication with stakeholders

24

Dustin Mobley, P.E.Process EngineerBlack & VeatchMobleyDR@BV.com

top related